Press Releases

The WHO Should Recognise Vaping’s Role in Harm Reduction


Amsterdam – May 25th 2018 – Fontem Ventures, owner of e-vapour brand blu, today calls on the World Health Organisation (WHO) to recognise the growing evidence that vaping can make a significant contribution to tobacco harm reduction, ahead of World No Tobacco Day 2018 on May 31st.

“The current generation of smokers are ill-served by the WHO’s silence on vaping. It’s time for change, and World No Tobacco Day would be the perfect opportunity for the WHO to talk about vaping and give smokers across the world the best information on how to make the switch from combustible tobacco,” said Andrew Gregson, Director of Corporate & Legal Affairs at Fontem Ventures.

Article 1(d) of the Framework Convention on Tobacco Control (FCTC) defines tobacco control as “a range of supply, demand and harm reduction strategies that aim to improve the health of a population by eliminating or reducing their consumption of tobacco products and exposure to tobacco smoke.”

E-vapour products like e-cigarettes contain no tobacco¹, and peer reviewed scientific evidence² suggests that switching from smoking to e-vapour products will substantially reduce exposure to harmful toxicants³ found in tobacco cigarette smoke. Some health bodies have even concluded that vaping could be 95% less harmful than smoking tobacco cigarettes4.

However, thus far the WHO has not recognised the harm reduction potential of vaping, missing a significant opportunity to accelerate the move away from tobacco products. This stands in stark contrast to state and non-state actors in WHO member countries like the UK and France5, who already acknowledge the role vaping can play in harm reduction.

“Data showing the decline of smoking rates in countries where vaping is recognised as an alternative for smokers is incontrovertible6, and a clear, evidence-based position on vaping would strengthen public health campaigns targeting smokers. The time for candour is now,” said Andrew Gregson.

Media ContactJames Campbell
Senior Communications Manager
+31 6 14426896



²Article 14 The WHO FCTC states that “each Party shall develop and disseminate appropriate, comprehensive and integrated guidelines based on scientific evidence and best practices, taking into account national circumstances and priorities, and shall take effective measures to promote cessation of tobacco use and adequate treatment for tobacco dependence” The body of scientific evidence supporting the harm reduction potential of vaping is now significant and a useful summary can be found at the bottom of this press release. 


⁴British Medical Association:

⁵France – Institut National de Cancer –

See Fontem Ventures infographic on the UK experience

blu was founded in the USA in 2009 and is one of the original e-cigarette brands. It was acquired by Fontem Ventures in 2015. As one of the world’s most recognizable vape brands, blu offers adult smokers’ choice through high-quality e-vapour products and e-liquids.

Nerudia was established in 2013 and became part of Imperial Brands in 2017. It is the home of innovation and technology R&D for Next Generation Products (NGP) which includes e-vapour, heated tobacco and oral nicotine delivery. Nerudia is dedicated to creating a world where smokers have choice.

Fontem Ventures is a subsidiary of Imperial Brands PLC, a global consumer organisation and the fourth largest international tobacco company in the world, operating across 120 markets.

[contact-form-7 404 "Not Found"]